0
0
Chinese researchers have identified a new bat coronavirus, HKU5-CoV-2, which utilizes the same human receptor as SARS-CoV-2, the virus responsible for the COVID-19 pandemic. This discovery raises concerns about the virus’s potential to transmit from animals to humans.
The study, led by virologist Shi Zhengli—often referred to as “batwoman” for her extensive research on bat coronaviruses—was conducted at the Guangzhou Laboratory in collaboration with other scientific institutions. The researchers found that HKU5-CoV-2 can bind to the human angiotensin-converting enzyme 2 (ACE2) receptor, a mechanism similar to that of SARS-CoV-2. This suggests that the virus has the potential to infect human cells.
While the virus has not yet been identified in humans, the study underscores the importance of continuous surveillance and research to monitor potential zoonotic threats. The researchers emphasize the need for ongoing vigilance to prevent future pandemics.
This discovery has reignited discussions about the origins of SARS-CoV-2 and the potential risks associated with viruses that can cross species barriers. The Wuhan Institute of Virology, where Dr. Shi Zhengli conducts her research, has been a focal point in debates regarding the origins of the COVID-19 pandemic.
Health experts advise that while the immediate risk to humans is considered low, the situation warrants close monitoring. The ability of HKU5-CoV-2 to bind to the human ACE2 receptor highlights the necessity for ongoing research and preparedness to mitigate potential public health threats.
Disclaimer: The information provided in this article is based on the latest available research and news reports. As scientific understanding evolves, new findings may emerge. Readers are encouraged to consult health authorities and scientific publications for the most current information.
Source:https://economictimes.indiatimes.com/news/international/global-trends/another-pandemic-china-scientists-discover-new-bat-coronavirus-hku5-cov-2-that-poses-risk-of-animal-to-human-transmission/articleshow/118453245.cms?from=mdr
